Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2

• Mani Shankar Babu,

  Roles Investigation

  Affiliation Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America

  ⨯
• Sailendra Mahanta,

  Roles Investigation

  Affiliation Structural Biology and Nanomedicine Laboratory, Department of Biotechnology and Medical Engineering, National Institute of Technology, Rourkela, Odisha, India

  ⨯
• Alexander J. Lakhter,

  Roles Investigation

  Affiliation Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America

  ⨯
• Takashi Hato,

  Roles Investigation

  Affiliation Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, United States of America

  ⨯
• Subhankar Paul,

  Roles Supervision

  Affiliation Structural Biology and Nanomedicine Laboratory, Department of Biotechnology and Medical Engineering, National Institute of Technology, Rourkela, Odisha, India

  ⨯
• Samisubbu R. Naidu

  Roles Conceptualization, Funding acquisition, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: naidus@iu.edu

  Affiliation Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America

  http://orcid.org/0000-0001-9411-660X

  ⨯